Jul 01, 2026 | ProBio Inc.

ProBio's AAV Manufacturing Excellence Powers UC Irvine and GlyTR Therapeutics First‑in‑Class Pan-Cancer CAR‑T Program

UC Irvine researchers and GlyTR Therapeutics have advanced a groundbreaking, first-in-class pan-cancer CAR-T platform with the potential to expand the reach of cell therapy into solid tumors.

Jun 23, 2026 | UC Irvine School of Medicine

Researchers Develop a Potential Blood Test for Diagnosing ALS

UC Irvine researchers are part of an international team developing a new blood test to diagnose ALS and track its progression.

Jun 18, 2026 | UC Irvine School of Medicine

CBD to Alleviate ‘Chemo Brain’ in Cancer Survivors

A new study by UC Irvine researchers suggests that CBD can help treat “brain fog” for people with cancer-therapy-related cognitive impairments (CRCI), addressing an unmet medical need.

Jun 16, 2026 | Elsevier

Utah’s stricter 0.05 BAC limit significantly reduces drunk driving fatalities

A study in the American Journal of Preventive Medicine provides timely evidence to other states considering similar laws that lowering the legal alcohol limit can save lives.

Jun 16, 2026 | UC Irvine News

Immunology Researcher Secures Nearly $4 Million NIH Grant to Advance Therapeutic Vaccine to Help End Genital Herpes

UC Irvine immunologist Lbachir BenMohamed receives NIH grant to support an innovative ‘Prime/Pull/Keep’ strategy to achieve long-lasting protection against HSV-2.

Jun 10, 2026 | UC Irvine School of Medicine

Sounding the Alarm: A New Strategy in Cancer Therapy

A new study by UC Irvine researchers has identified a mechanism that could enhance both DNA damage and inflammatory signaling in tumor cells, potentially improving cancer treatment response.

Jun 10, 2026 | UC Irvine News

UC Irvine's Oswald Steward is Awarded 2026 Kavli Prize in Neuroscience

UC Irvine neuroscientist Oswald Steward receives one of the world's most prestigious honors in science for his breakthrough discoveries on how the brain learns, adapts and heals.

May 29, 2026 | UC Irvine School of Medicine

Save the Brain, Kill the Cancer: Extracellular Vesicle (EV) Treatment for Glioblastoma Patients

UC Irvine researchers find that human neural stem-cell-derived extracellular vesicles (EVs) improve cognitive function following glioma chemoradiation therapy.

May 15, 2026 | UC Irvine School of Medicine

UC Irvine Researchers Discover Cellular ‘Tug-of-War’ That Shapes How Our Genes Are Expressed — With Potential Implications for Cancer Drug Safety

The study shows that two crucial steps in processing genetic messages — splicing and 3′ end processing — actively compete with each other to shape what RNA molecules are generated.

May 14, 2026 | UC Irvine News

W. M. Keck Foundation Gives $1.2 Million to UC Irvine to Support Early-Career Scientists

Six research teams, including one from the School of Medicine's Department of Physiology & Biophysics, were awarded bridge funding to sustain innovation amid federal funding uncertainty.